NDC 65090-001 - AniHist
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 65090-001
- Package NDCs from labels
- 65090-001-15, 65090-001-30
- Manufacturer
- AHC Products Inc | Delta Synthetic Co., Ltd. | Supriya Lifescience Ltd.
- Effective date
- 2022-01-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Drug Facts | AHC Products Inc | Delta Synthetic Co., Ltd. | Supriya Lifescience Ltd. | 2022-01-21 | OTC ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 65090-001-15 | AniHist | 566 g in 1 JAR | GRANULE | 566 | 117 | |
| 65090-001-30 | AniHist | 2264 g in 1 PAIL | GRANULE | 2264 | 117 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| GUAIFENESIN | ACTIVE INGREDIENT | 495W7451VQ | ANIHIST (GUAFENESIN AND PYRILAMINE MALEATE) GRANULE [AHC PRODUCTS INC] | 115 | |
| PYRILAMINE MALEATE | ACTIVE INGREDIENT | R35D29L3ZA | ANIHIST (GUAFENESIN AND PYRILAMINE MALEATE) GRANULE [AHC PRODUCTS INC] | 115 | |
| GUAIFENESIN | ACTIVE MOIETY | 495W7451VQ | ANIHIST (GUAFENESIN AND PYRILAMINE MALEATE) GRANULE [AHC PRODUCTS INC] | 115 | |
| PYRILAMINE | ACTIVE MOIETY | HPE317O9TL | ANIHIST (GUAFENESIN AND PYRILAMINE MALEATE) GRANULE [AHC PRODUCTS INC] | 115 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Maximum Strength Mucinex Fast-Max Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | Reckitt Benckiser LLC | 182222b5-a852-4dbe-b05f-a41d89806021 | 2026-05-12 | Warnings | 495W7451VQ |
| Maximum Strength Mucinex Fast-Max Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Reckitt Benckiser LLC | 8a790eeb-7d7d-4a94-9103-6ed09c04d596 | 2026-05-12 | Warnings | 495W7451VQ |
| Maximum Strength Mucinex Sinus-Max Pressure, Pain and Cough | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Reckitt Benckiser LLC | d03ef2fd-1a08-42c0-b69d-fd4e4285ccd3 | 2026-05-12 | Warnings | 495W7451VQ |
| Maximum Strength Mucinex Sinus-Max Severe Congestion and Pain | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Reckitt Benckiser LLC | cea08797-1d53-4434-be1a-144f2ded5f9d | 2026-05-12 | Warnings | 495W7451VQ |
| Maximum Strength Mucinex Sinus-Max Severe Congestion and Pain | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Reckitt Benckiser LLC | 2ef9d5de-e99e-4398-bf97-c7bef94498fa | 2026-05-12 | Warnings | 495W7451VQ |
| Mucinex Fast-Max Cold, Flu and Sore Throat | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Reckitt Benckiser LLC | c902b4fc-c71c-4ef2-b5cb-6c2bd019acbc | 2026-05-12 | Warnings | 495W7451VQ |
| Mucinex Fast-Max Severe Congestion and Cough | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | Reckitt Benckiser LLC | 3ff4c4ea-7628-4d2b-a6e9-d994c25baef4 | 2026-05-12 | Warnings | 495W7451VQ |
| Mucinex Fast-Max Cold, Flu and Sore Throat | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Reckitt Benckiser LLC | d7c18e95-8d7b-4550-9a20-fc704a114adb | 2026-05-12 | Warnings | 495W7451VQ |
| Mucinex Childrens Cough and Chest Congestion Mini-Melts Orange Creme | DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN | Reckitt Benckiser LLC | 66543190-1d3d-4259-ae73-d366ecbf9e52 | 2026-05-12 | Warnings | 495W7451VQ |
| Menstrual Relief | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | CVS Pharmacy | 289ec101-c9a3-45f1-b2cd-8eaf8e580130 | 2026-05-12 | Warnings | R35D29L3ZA |
| PMS Relief Maximum Strength | ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE | CVS Pharmacy | 760ee367-0625-48d7-98a7-84c69389ad3e | 2026-05-12 | Warnings | R35D29L3ZA |
| Menstrual Relief | ACETAMINOPHEN, CAFFEINE AND PYRILAMINE MALEATE | Target Corporation | bc65e205-64fd-4764-8c5e-2793af4e9adf | 2026-05-12 | Warnings | R35D29L3ZA |
| GUAIFENESIN DM | GUAIFENESIN AND DEXTROMETHORPHAN | Cardinal Health 107, LLC | 9cfb1abb-98c4-4e90-8dd7-fcffc112f988 | 2026-05-12 | Warnings | 495W7451VQ |
| Mucus Relief DM | DEXTROMETHORPHAN HBR, GUAIFENESIN | Walgreen Company | cad5da8c-65a6-44c4-a4c7-38f2c7fe43aa | 2026-05-11 | Warnings | 495W7451VQ |
| Severe Congestion and Cough | DEXTROMETHORPHAN HBR, GUAIFENESIN | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | 1efd1778-7ab1-4797-98c5-4637940ee3ec | 2026-05-11 | Warnings | 495W7451VQ |
| Multi-Symptom PMS Relief | ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | 81ef39e2-b91e-4d34-b594-4ba557cc319b | 2026-05-11 | Warnings | R35D29L3ZA |
| Maximum Strength Tussin DM Liquid filled Softgels | DEXTROMETHORPHAN HBR, GUAIFENESIN | AptaPharma Inc. | 39ad6cc9-d2b0-4b4a-8aa3-977905c9e6f1 | 2026-05-10 | Warnings | 495W7451VQ |
| DM Max CONGESTION and COUGH | DEXTROMETHORPHAN HBR, GUAIFENESIN | DeMoulas Market Basket | b12e26b2-79e4-45a5-9a90-4630f92457d0 | 2026-05-09 | Warnings | 495W7451VQ |
| Severe Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | HyVee Inc | 5a0ef8ae-f6d5-4388-b4da-6b7f025160b2 | 2026-05-08 | Warnings | 495W7451VQ |
| Dr. Simi Children s Cough | DEXTROMETHORPHAN HBR, GUAIFENESIN | Farmacias De Similares TX LLC | 5151740a-8270-7bb5-e063-6294a90ae387 | 2026-05-08 | Warnings | 495W7451VQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.